Amy van Andel Dvm, Mph

Amy Van Andel, DVM, MPH has a diverse work experience spanning over three decades. Amy currently holds the position of Vice President of Regulatory Affairs at MacroGenics, Inc. since June 2022. Prior to this, they served as Vice President of Regulatory Affairs at Molecular Templates from August 2020 to June 2022.

Amy's extensive career includes various leadership roles at Boehringer Ingelheim, where they worked for a significant period of time. Amy was the Executive Director of Regulatory Affairs and US Oncology Leader from January 2008 to August 2020. Before that, they served as the Executive Director of Medical Administration and Compliance from November 2004 to December 2007. Additionally, they held the position of Senior Associate Director of Clinical Research from August 1996 to October 2004.

Amy started their career as an Associate Veterinarian at Fairfield Equine Assoc P C from June 1992 to June 1994. Amy gained valuable experience as an Intern in Equine Ambulatory Service at The Ohio State University from June 1991 to June 1992.

Overall, Amy Van Andel has a strong background in regulatory affairs, veterinary medicine, and clinical research, making their a valuable asset in the healthcare industry.

Amy Van Andel, DVM, MPH has a diverse education history. Amy attended the University of Florida and obtained a degree in Veterinary Medicine. Amy also studied Microbiology at the same university. Amy later pursued further education at the Yale University School of Medicine, where they earned a Master's in Public Health with a specialization in epidemiology.